These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24590894)

  • 1. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
    Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
    Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity.
    Markosyan N; Chen EP; Evans RA; Ndong V; Vonderheide RH; Smyth EM
    Breast Cancer Res; 2013; 15(5):R75. PubMed ID: 24004819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors.
    Markosyan N; Chen EP; Ndong VN; Yao Y; Sterner CJ; Chodosh LA; Lawson JA; Fitzgerald GA; Smyth EM
    Carcinogenesis; 2011 Oct; 32(10):1441-9. PubMed ID: 21771729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.
    Racioppi L; Nelson ER; Huang W; Mukherjee D; Lawrence SA; Lento W; Masci AM; Jiao Y; Park S; York B; Liu Y; Baek AE; Drewry DH; Zuercher WJ; Bertani FR; Businaro L; Geradts J; Hall A; Means AR; Chao N; Chang CY; McDonnell DP
    Nat Commun; 2019 Jun; 10(1):2450. PubMed ID: 31164648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
    Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
    Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.
    Barakat DJ; Suresh R; Barberi T; Pienta KJ; Simons BW; Friedman AD
    PLoS One; 2018; 13(1):e0191188. PubMed ID: 29324844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
    Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
    Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth.
    Achyut BR; Angara K; Jain M; Borin TF; Rashid MH; Iskander ASM; Ara R; Kolhe R; Howard S; Venugopal N; Rodriguez PC; Bradford JW; Arbab AS
    Sci Rep; 2017 Oct; 7(1):13754. PubMed ID: 29062041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premetastatic soil and prevention of breast cancer brain metastasis.
    Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
    Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
    Maeda Y; Echizen K; Oshima H; Yu L; Sakulsak N; Hirose O; Yamada Y; Taniguchi T; Jenkins BJ; Saya H; Oshima M
    Cancer Prev Res (Phila); 2016 Mar; 9(3):253-63. PubMed ID: 26888865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
    Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
    Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.
    Zhang Y; Lv D; Kim HJ; Kurt RA; Bu W; Li Y; Ma X
    Cell Res; 2013 Mar; 23(3):394-408. PubMed ID: 23266888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
    Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
    Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
    Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
    Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
    Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
    Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.